Cerevel Therapeutics Holdings, Inc.·4

Feb 8, 8:25 PM ET

DiPietro Kenneth 4

4 · Cerevel Therapeutics Holdings, Inc. · Filed Feb 8, 2023

Insider Transaction Report

Form 4
Period: 2023-02-06
DiPietro Kenneth
Chief Human Resources Officer
Transactions
  • Award

    Restricted Stock Units

    2023-02-06+13,91313,913 total
    Common Stock (13,913 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-02-06+54,74954,749 total
    Exercise: $34.41Exp: 2033-02-06Common Stock (54,749 underlying)
Footnotes (3)
  • [F1]25% of this option shall vest and become exercisable on February 6, 2024, with the remainder vesting in thirty-six (36) monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
  • [F2]The shares reported in this transaction represent Restricted Stock Units ("RSUs") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock.
  • [F3]The RSUs vest in four equal annual installments on each of February 6, 2024, February 6, 2025, February 6, 2026 and February 6, 2027, subject to the Reporting Person's continued service on each such vesting date.

Documents

2 files